产品编号 :
Cas No. :
CAS No. |
103833-72-3 |
|---|---|
中文名称 |
(R)-2-(2-氧代吡咯烷-1-基)丁酸 |
英文名称 |
(R)-2-(2-Oxopyrrolidin-1-yl)butanoic acid |
别名 |
(R)-α-Ethyl-2-oxo-1-Pyrrolidineacetic acid;(R)-2-(2-oxopyrrolidin-1-yl)butyric acid;(R)-alpha-Ethyl-2-oxo-1-pyrrolidineacetic acid (LevetiracetaM acid);LEVETIRACETAM ACID;(R)-alpha-Ethyl-2-oxo-1-pyrrolidineacetic acid;Levetiracetam Carboxylic Acid;(.alpha.R)-.alpha.-ethyl-2-oxo-1-Pyrrolidineacetic acid;(2R)-2-(2-oxopyrrolidin-1-yl)butanoic acid |
标准英文名 |
(R)-2-(2-oxopyrrolidin-1-yl)butanoic acid |
MDL No. |
MFCD13151944 |
分子式 |
C8H13NO3 |
分子量 |
171.20 |
精确分子量 |
171.09 |
SMILES |
O=C(O)[C@@H](CC)N1C(CCC1)=O |
标准SMILES |
CC[C@H](C(O)=O)N1CCCC1=O |
用途 |
Levetiracetam acid is an intermediate in the synthesis of levetiracetam, a novel antiepileptic drug developed by UCB (Belgium), which was approved by the FDA in April 2000 and marketed in the United States and the European Union for the treatment of partial-onset seizures and secondary generalized tonic-clonic seizures. |
InChIKey |
IODGAONBTQRGGG-ZCFIWIBFSA-N |
|
|
评论 |
|---|